Skip to content

BENU Management

Active
Public limited companyfounded 2001active for 25 yearsAvenue Pasteur 2, 1300 Wavre, Belgium27 active companies are registered at this addressKBO/BCE: BE 0474.171.632
Summary

BENU Management has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €51.1m and a net result of €436,835. Equity remains stable across the filed financial years (±0.3% per year). Its solvency ranks better than 44% of 317 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
Largest company by equity in Walloon Brabant, Retail trade sector1 site
Size
€9.5mturnover 2026
Staff
27.2 FTE
Equity
€51.1m
Profit
€436,835
Financial health
83 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
PHOENIX Pharmahandel GmbH & Co KG
Board
4 members
Holdings
2
Auditor: Forvis Mazars Réviseurs d'Entreprises SRL/Bedrijfsrevisoren BVAccounts 67 days early4 of 36 deeds read
Why 83raises riskLiquidity: current ratio 0.08Sector: Retail trade (NACE 47)lowers riskFounded in 2001Size: turnover €9.5m, 27.2 FTE, total assets €163.0mShow the evidence

Checked score

Score 2026
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 37% of its sector peers (NACE 47, small)
Financial strength · tick = 2025
Weak
Solvency 56-2
equity 31.3% of total assets
Liquidity 27-2
short-term debt 68.7%
Profitability 53+1
return on assets 0.3%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,692 companies, NACE 47, small)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025lowest value 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.1 percentage points vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025highest value 08-2025: 0.3%▼ -0.1 percentage points vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.4%▲ +0.1 percentage points vs 05-2026 07-2026: 0.3%▼ -0.1 percentage points vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €950,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.08, compared with 0.01 in 2025, below 1; short-term debt: 68.7% of total assets), and 68.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 51% on solvency, 26% on liquidity, 34% on profitability and 37% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 0.08
NBB · annual accounts
lowers risk · Founded in 2001
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: turnover €9.5m, 27.2 FTE, total assets €163.0m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 25-06-2026, 67 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
67 days early
2025
53 days early
2024
53 days early
2023
28 days early
2022
32 days early
2021
44 days early
2020
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 41 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today. The company usually files around 9 July (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-01-2027 year end31-08-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Reappointments: An Marin, Amaud Berken and…Gazette deed
  2. Annual accounts filedfinancial year 2026 · full…
  3. Highest result from 2019 to 2026net €436,835 ▲1.7%

Key points

  • Positive: Largest company by equity in Walloon Brabant, Retail trade sectorin the Checked rankings No. 1 View
  • New directorslatest change 17-06-2026 · 4 in office 3 joined View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
  • Controlled by PHOENIX Pharmahandel GmbH &…known shareholders 100% parent View

By topic

Financials

Financial year
2026
Turnover
€9.5m
Profit
€436,835
Solvency
31.3%
Turnover▼ 3.8%
Net result
20192026
Go to Financials

Board & ownership

Board
4 members
Parent
PHOENIX Pharmahandel GmbH &…
Known shareholders
100%
Auditor
Forvis Mazars Réviseurs d'Entreprises…
  • Amaud BerkenDirector
  • An MarinDirector
  • Philippe LacroixDirector
  • Arnaud BerkenDirector
Go to Board & ownership

Timeline

Events
43
Since
2002
Next accounts
by 31-08-2027
  1. 14-07-2025Resignation: Deloitte Bedrijfsrevisoren/Réviseurs d'entreprises BV SRL (statutory…
  2. 09-07-2025Annual accounts filed
  3. 09-07-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
23-02-2001
Year ends
31-01
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.